Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Syn57: The Ultimate Stripped-Down Synthetic Bacteria Unveiled
Biotech & Bioprocessing Syn57: The Ultimate Stripped-Down Synthetic Bacteria Unveiled

In an era where science continually redefines the boundaries of life, a remarkable achievement has emerged from the Medical Research Council Laboratory of Molecular Biology, capturing the attention of the global scientific community with the introduction of Syn57. This synthetic bacterium, a

How Can Digital Twins Transform GI Disorder Diagnosis?
Tech & Innovation How Can Digital Twins Transform GI Disorder Diagnosis?

Imagine a world where chronic stomach pain, bloating, and discomfort no longer remain medical mysteries, even when standard tests show nothing amiss, and where innovative solutions offer hope to millions. Gastrointestinal (GI) disorders affect countless individuals globally, often leaving patients

How Does Avtozma IV Expand Treatment for Cytokine Release?
Management & Regulatory How Does Avtozma IV Expand Treatment for Cytokine Release?

Imagine a healthcare landscape where life-threatening conditions like cytokine release syndrome (CRS), triggered by immunotherapies or severe infections, can be managed with greater affordability and access. This vision is becoming a reality with the recent FDA approval of Celltrion’s Avtozma IV, a

Why Is Velvet Robot Coffee Lab Closing Its Roscoe Location?
Tech & Innovation Why Is Velvet Robot Coffee Lab Closing Its Roscoe Location?

We’re sitting down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research, development, and cutting-edge technology within the industry. With a career dedicated to pushing the boundaries of innovation, Ivan offers a unique perspective on how science and tech intersect

Tech Boosts Brain Health in Older Adults, Study Finds
Tech & Innovation Tech Boosts Brain Health in Older Adults, Study Finds

What if the very devices often criticized for draining mental energy could instead be a secret weapon for preserving brain health in seniors? Picture a 70-year-old grandmother, once hesitant to touch a smartphone, now confidently video-calling her grandchildren across the country and solving daily

How Is BICO Group AB Positioning for Biopharma Growth?
Tech & Innovation How Is BICO Group AB Positioning for Biopharma Growth?

In the fast-evolving world of biopharma manufacturing, where innovation meets urgent medical needs, BICO Group AB stands as a pivotal player with a sharp focus on lab automation and supply chain solutions. The biopharma sector, particularly the realm of cell and gene therapies (CGTs), is on a

Review of Modeyso Brain Cancer Treatment
Research & Development Review of Modeyso Brain Cancer Treatment

Imagine a diagnosis so devastating that it offers a median survival of just one year, primarily striking children and young adults with little hope for effective intervention. Diffuse midline glioma with an ### K27M mutation, an ultra-rare and aggressive brain cancer, affects roughly 2,000

Hong Kong Watchdog Urges Telehealth Regulation Overhaul
Tech & Innovation Hong Kong Watchdog Urges Telehealth Regulation Overhaul

In a rapidly evolving digital healthcare landscape, Hong Kong finds itself at a critical juncture where the promise of telehealth is overshadowed by significant regulatory shortcomings that threaten consumer safety and trust. A recent report by the Consumer Council, released in mid-August, has

Groundbreaking ALS Research Uncovers Protective Gene Mechanisms
Research & Development Groundbreaking ALS Research Uncovers Protective Gene Mechanisms

Amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease that relentlessly attacks motor neurons responsible for muscle movement, has long puzzled scientists and clinicians with its rapid progression and fatal outcomes. A recent study, conducted by a collaborative team from

Can AI Revolutionize Drug Discovery with Recursion Pharmaceuticals?
Research & Development Can AI Revolutionize Drug Discovery with Recursion Pharmaceuticals?

In a world where the intersection of technology and healthcare is becoming ever more critical, Recursion Pharmaceuticals emerges as a trailblazer with a mission to transform the landscape of drug discovery through artificial intelligence (AI). Listed on NASDAQ under the ticker RXRX, this innovative

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later